United States

Ankur Banerjee

Pfizer to spinoff, merge off-patent drugs unit with Mylan

Jul 29 2019

Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar. | Video

AstraZeneca raises sales forecast after second-quarter cancer drug, China boost

Jul 25 2019

AstraZeneca Plc raised its product sales forecast for 2019 on Thursday after second-quarter results beat analysts' expectations, thanks to strong sales from cancer medicines and emerging markets, especially China.

WRAPUP 1-GSK raises 2019 earnings expectations after standout quarter for Shingrix

Jul 24 2019

July 24 GlaxoSmithKline beat second quarter profit expectations with the help of strong demand for its shingles vaccine, prompting the British drugmaker to forecast a smaller fall in profit this year than originally anticipated.

UPDATE 7-AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan

Jun 25 2019

June 25 Drugmaker AbbVie Inc said on Tuesday it would acquire Allergan Plc for about $63 billion, giving AbbVie control over the lucrative wrinkle treatment Botox and buying time to seek new growth before its blockbuster arthritis treatment Humira loses U.S. patent protection.

Migraine in pregnancy linked with complications for mothers and babies

Jun 25 2019

(Reuters Health) - Pregnant women with migraine headaches are more likely to develop complications, and their babies are at higher risk for complications early after birth, too, a large study from Denmark suggests.

Melanoma can occur on skin that doesn't get much sun

Jun 04 2019

Spending time in the sun without protection increases the risk of melanoma, but the potentially deadly skin cancer can occur even on sites with minimal sun exposure, doctors warn.

Light physical activity might help keep the brain young

May 15 2019

A recent study suggests that light physical activity may help stave off signs of aging in the brain.

GSK sees shingles vaccine sales rising, as free cash flow concerns weigh

May 01 2019

GlaxoSmithKline forecast on Wednesday that 2019 sales of its shingles vaccine would be more than 1 billion pounds ($1.3 billion) but the British drugmaker's shares slipped on concerns about its pharmaceutical business and free cash flow.

Dads' smoking linked with fetal heart problems

Apr 30 2019

(Reuters Health) - Unborn babies are at higher risk of heart defects not just when mothers smoke, but when fathers smoke, too, a new study suggests.

Cancer patients using alternative therapies may hesitate to tell doctors

Apr 26 2019

(Reuters Health) - One in three U.S. patients with a cancer diagnosis has recently used non-standard therapies to manage their disease - but many haven't told their doctors, survey data suggest.

World News